Joint effects of urinary arsenic methylation capacity with potential modifiers on arsenicosis: A cross-sectional study from an endemic arsenism area in Huhhot Basin, northern China

Environmental Research

Volumn 132, Issue , 2014, Pages 281-289

  Zhang, Qiang ^a   Wang, Da ^b   Zheng, Quanmei ^b   Zheng, Yi ^b   Wang, Huihui ^b   Xu, Yuanyuan ^b   Li, Xin ^b   Sun, Guifan ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic methylation; Arsenicosis; China; Metabolites; Skin lesion

Indexed keywords

ARSENIC; CACODYLIC ACID; METHANEARSONIC ACID;

AGE; ARSENIC; GENDER; HEALTH RISK; MALE; METHYLATION; SKIN;

ADULT; ARSENIC METHYLATION CAPACITY; ARSENIC POISONING; ARTICLE; CHEMICAL PARAMETERS; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPIGMENTATION; ENDEMIC DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; METHYLATION; PRIMARY METHYLATION INDEX; PRIORITY JOURNAL; RISK FACTOR; SCHOOL; SECONDARY METHYLATION INDEX; SKIN DEFECT; SKIN PIGMENTATION; URINE; URINE LEVEL;

CHINA; HUHHOT BASIN; NEI MONGGOL;

ARSENIC METHYLATION; ARSENICOSIS; CHINA; METABOLITES; SKIN LESION;

ADULT; AGED; ARSENIC; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METHYLATION; MIDDLE AGED; RISK FACTORS; SKIN DISEASES;

EID: 84900424582     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.04.036     Document Type: Article

References (56)

1. Abhyankar L.N., Jones M.R., Guallar E., Navas-Acien A. Arsenic exposure and hypertension: a systematic review. Environ. Health Perspect. 2012, 120:494-500.
2. Agusa T., Fujihara J., Takeshita H., Iwata H. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int. J. Mol. Sci. 2011, 12:2351-2382.
3. Ahsan H., Chen Y., Kibriya M.G., Slavkovich V., Parvez F., Jasmine F., Gamble M.V., Graziano J.H. Arsenic metabolism, genetic gusceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1270-1278.
4. Aposhian H.V., Zakharyan R.A., Avram M.D., Sampayo-Reyes A., Wollenberg M.L. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol. Appl. Pharmacol. 2004, 198:327-335.
5. Balakumar P., Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc. Toxicol. 2009, 9:169-176.
6. Basu A., Mitra S., Chung J., Guha Mazumder D.N., Ghosh N., Kalman D., von Ehrenstein O.S., Steinmaus C., Liaw J., Smith A.H. Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ. Health Perspect. 2011, 119:1308-1313.
7. Bhattacharjee P., Banerjee M., Giri A.K. Role of genomic instability in arsenic-induced carcinogenicity. A review. Environ. Int. 2013, 53:29-40.
8. Chen J.W., Wang S.L., Wang Y.H., Sun C.W., Huang Y.L., Chen C.J., Li W.F. Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of Southwestern Taiwan. Chemosphere 2012, 88:432-438.
9. Chen Y., Graziano J.H., Parvez F., Hussain I., Momotaj H., van Geen A., Howe G.R., Ahsan H. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 2006, 17:459-467.
10. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., Argos M., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Levy D., van Geen A., Ahsan H. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. Br. Med. J. 2011, 342:d2431.
11. Chen Y., Wu F., Liu M., Parvez F., Slavkovich V., Eunus M., Ahmed A., Argos M., Islam T., Rakibuz-Zaman M., Hasan R., Sarwar G., Levy D., Graziano J., Ahsan H. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ. Health Perspect. 2013, 121:832-838.
12. Chung C.J., Hsueh Y.M., Bai C.H., Huang Y.K., Huang Y.L., Yang M.H., Chen C.J. Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer. Cancer Causes Control 2009, 20:1653-1661.
13. Concha G., Vogler G., Nermell B., Vahter M. Intra-individual variation in the metabolism of inorganic arsenic. Int. Arch. Occup. Environ. Health 2002, 75:576-580.
14. Engström K., Vahter M., Mlakar S.J., Concha G., Nermell B., Raqib R., Cardozo A., Broberg K. Polymorphisms in arsenic (+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ. Health Perspect. 2011, 119:182-188.
15. Gamble M.V., Liu X., Ahsan H., Pilsner R., Ilievski V., Slavkovich V., Parvez F., Levy D., Factor-Litvak P., Graziano J.H. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ. Health Perspect. 2005, 113:1683-1688.
16. Gao J., Yu J., Yang L. Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China. Int. J. Environ. Res. Public Health 2011, 8:1991-2008.
17. Gomez-Rubio P., Roberge J., Arendell L., Harris R.B., O'Rourke M.K., Chen Z., Cantu-Soto E., Meza-Montenegro M.M., Billheimer D., Lu Z., Klimecki W.T. Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. Toxicol. Appl. Pharmacol. 2011, 252:176-182.
18. Gong Z., Lu X., Cullen W.R., Le X.C. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 2001, 16:1409-1413.
19. Grashow R., Zhang J., Fangm S.C., Weisskopf M.G., Christiani D.C., Kile M.L., Cavallari J.M. Inverse association between toenail arsenic and body mass index in a population of welders. Environ. Res. 2014, 131:131-133.
20. Gruber J.F., Karagas M.R., Gilbert-Diamond D., Bagley P.J., Zens M.S., Sayarath V., Punshon T., Morris J.S., Cottingham K.L. Associations between toenail arsenic concentration and dietary factors in a New Hampshire population. Nutr. J. 2012, 11:45.
21. Hall M.N., Gamble M.V. Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J. Toxicol. 2012, 2012:595307.
22. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456.
23. Huang Y.K., Huang Y.L., Hsueh Y.M., Yang M.H., Wu M.M., Chen S.Y., Hsu L.I., Chen C.J. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 2008, 19:829-839.
24. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 2000, 72:5172-5177.
25. Li L., Ekström E.C., Goessler W., Lönnerdal B., Nermell B., Yunus M., Rahman A., El Arifeen S., Persson L.A., Vahter M. Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women. Environ. Health Perspect. 2008, 116:315-321.
26. Li X., Li B., Xi S., Zheng Q., Wang D., Sun G. Association of urinary monomethylated arsenic concentration and risk of hypertension: a cross-sectional study from arsenic contaminated areas in northwestern China. Environ. Health 2013, 12:37.
27. Li X., Li B., Xu Y., Wang Y., Jin Y., Itoh T., Yoshida T., Sun G. Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area. Environ. Toxicol. 2011, 26:118-123.
28. Lindberg A.L., Ekström E.C., Nermell B., Rahman M., Lönnerdal B., Persson L.A., Vahter M. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ. Res. 2008, 106:110-120.
29. Lindberg A.L., Rahman M., Persson L.A., Vahter M. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol. Appl. Pharmacol. 2008, 230:9-16.
30. Marchiset-Ferlay N., Savanovitch C., Sauvant-Rochat M.P. What is the best biomarker to assess arsenic exposure via drinking water?. Environ. Int. 2012, 39:150-171.
31. McCarty K.M., Chen Y.C., Quamruzzaman Q., Rahman M., Mahiuddin G., Hsueh Y.M., Su L., Smith T., Ryan L., Christiani D.C. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ. Health Perspect. 2007, 115:341-345.
32. Melkonian S., Argos M., Pierce B.L., Chen Y., Islam T., Ahmed A., Syed E.H., Parvez F., Graziano J., Rathouz P.J., Ahsan H. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am. J. Epidemiol. 2011, 173:183-191.
33. Navas-Acien A., Francesconi K.A., Silbergeld E.K., Guallar E. Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ. Res. 2011, 111:110-118.
34. Navas-Acien A., Umans J.G., Howard B.V., Goessler W., Francesconi K.A., Crainiceanu C.M., Silbergeld E.K., Guallar E. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the strong heart study. Environ. Health Perspect. 2009, 117:1428-1433.
35. Pan W.C., Seow W.J., Kile M.L., Hoffman E.B., Quamruzzaman Q., Rahman M., Mahiuddin G., Mostofa G., Lu Q., Christiani D.C. Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh. Am. J. Epidemiol. 2013, 178:1563-1570.
36. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Aposhian H.V. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163:203-207.
37. Pilsner J.R., Liu X., Ahsan H., Ilievski V., Slavkovich V., Levy D., Factor-Litvak P., Graziano J.H., Gamble M.V. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ. Health Perspect. 2009, 117:254-260.
38. Rodriguez-Lado L., Sun G., Berg M., Zhang Q., Xue H., Zheng Q., Johnson C.A. Groundwater arsenic contamination throughout China. Science 2013, 34:866-868.
39. Seow W.J., Pan W.C., Kile M.L., Baccarelli A.A., Quamruzzaman Q., Rahman M., Mahiuddin G., Mostofa G., Lin X., Christiani D.C. Arsenic reduction in drinking water and improvement in skin lesions: a follow-up study in Bangladesh. Environ. Health Perspect. 2012, 120:1733-1738.
40. Smedley P.L., Zhang M., Zhang G., Luo Z. Mobilisation of arsenic and other trace elements in fluviolacustrine aquifers of the Huhhot Basin, Inner Mongolia. Appl. Geochem. 2003, 18:1453-1477.
41. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74:289-299.
42. Su C.T., Lin H.C., Choy C.S., Huang Y.K., Huang S.R., Hsueh Y.M. The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescents. Sci. Total Environ. 2012, 414:152-158.
43. Sun G. Arsenic contamination and arsenicosis in China. Toxicol. Appl. Pharmacol. 2004, 198:268-271.
44. Sun G., Xu Y., Li X., Jin Y., Li B., Sun X. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ. Health Perspect. 2007, 115:648-652.
45. Sun G., Xu Y., Zheng Q., Xi S. Arsenicosis history and research progress in Mainland China. Kaohsiung J. Med. Sci. 2011, 27:377-381.
46. Tseng C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicol. Appl. Pharmacol. 2009, 235:338-350.
47. Tseng C.H., Huang Y.K., Huang Y.L., Chung C.J., Yang M.H., Chen C.J., Hsueh Y.M. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 2005, 206:299-308.
48. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 1999, 82:69-88.
49. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.
50. Valenzuela O.L., Borja-Aburto V.H., Garcia-Vargas G.G., Cruz-Gonzalez M.B., Garcia-Montalvo E.A., Calderon-Aranda E.S., Del Razo L.M. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 2005, 113:250-254.
51. Wang S.L., Chang F.H., Liou S.H., Wang H.J., Li W.F., Hsieh D.P. Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ. Int. 2007, 33:805-811.
52. Wen J., Wen W., Li L., Liu H. Methylation capacity of arsenic and skin lesions in smelter plant workers. Environ. Toxicol. Pharmacol. 2012, 34:624-630.
53. Wu C.C., Huang Y.K., Chung C.J., Huang C.Y., Pu Y.S., Shiue H.S., Lai L.A., Lin Y.C., Su C.T., Hsueh Y.M. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma. Toxicol. Appl. Pharmacol. 2013, 272:30-36.
54. Xi S., Zheng Q., Zhang Q., Sun G. Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China. Int. Arch. Occup. Environ. Health. 2011, 84:347-353.
55. Xu Y., Wang Y., Zheng Q., Li X., Li B., Jin Y., Sun X., Sun G. Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults. Toxicol. Appl. Pharmacol. 2008, 232:142-149.
56. Yu Z.M., Fung B., Murimboh J.D., Parker L., Dummer T.J. What is the role of obesity in the aetiology of arsenic-related disease?. Environ. Int. 2014, 66:115-123.